Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum

Toxicology

Volumn 170, Issue 3, 2002, Pages 165-171

  Leret, M L ^a   San Millan J A ^a   Fabre, E ^a   Gredilla, R ^a   Barja, G ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

ATP levels; Brain; Deprenyl; Free radical; GSH; MPP+; MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; GLUTATHIONE; NEUROTRANSMITTER; SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; LOCOMOTION; MALE; MOTOR ACTIVITY; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; RAT; TURNOVER TIME;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIPARKINSON AGENTS; BEHAVIOR, ANIMAL; CATECHOLAMINES; DOPAMINE; DOPAMINE AGENTS; GLUTATHIONE; MALE; NEOSTRIATUM; OXIDATION-REDUCTION; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; SELEGILINE; STEREOTAXIC TECHNIQUES;

EID: 0037168983     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(01)00541-8     Document Type: Article

References (34)

1. Age and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system
2. The ability of (-)-deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective
3. The effect of a long-term (6 months) treatment with (-)-deprenyl on antioxidant enzyme activities in selective brain regions in old Fisher 344 rats
4. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement
5. Threshold effects and control of oxidative phosphorylation in non-synaptic rat brain mitochondria
6. 2 and ATP production and on dopamine and DOPAC in the striatum
7. Molecular mechanisms for neurodegeneration: Synergism between reactive oxygen species, calcium and excitotoxic amino acids
8. Pharmacology of Selegiline
9. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA
10. Pharmacological basis of the therapeutic effect of (-)-deprenyl in age-related neurological disease
11. Chronic parkinsonism in human due to a product of meperidine analog synthesis
12. Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes
13. Effect of D9-tetrahydrocannabinol on short-term memory in the rat
14. L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro
15. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion
16. Ethiology and pathogenesis of Parkinson's disease
17. The effect of deprenyl and levodopa on the progression of Parkinson's disease
18. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
19. Aminoethylcysteine ketimine decarboxilated dimmer protects submitochondrial particles from lipid peroxidation at a concentration not inhibitory of electron transport
20. Alkaline hydrolysis of N-ethylmaleimide allows a rapid assay of glutathione disulfide in biological samples
21. Mitochondrial complex I deficiency in Parkinson's disease
22. Monoamine oxidase: From genes to behaviour
23. Alterations in glutathione levels in Parkinson's disease and other neurodegenetive disorders affecting basal ganglia
24. Glutathione-related enzymes in brain in Parkinson's disease
25. Reduced and oxidised glutathione in the substantia nigra of patients with Parkinson's disease
26. Dopamine turnorver and glutathione oxidation: Implication for Parkinson disease
27. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration
28. Reduction of neuronal apoptosis by small molecules: Promises for new approaches to neurological therapy
29. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
30. Chronic glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration
31. +- and MPTP- induced dopamine overflow in microdialysates of striatum and nucleus accumbens
32. + toxicity in vivo
33. + toxicity in nigral dopaminergic neurones